An investigational approach to diagnosis of prostate cancer uses sound waves to extract “bubbles of information” from cells. (Cancer Research UK)
In a first-ever clinical trial, a treatment strategy that combines imaging and targeted radiation, or radiotheranostics, will “light up” tumors at the molecular level for precise delivery of radiation to hard-to-treat metastatic osteosarcoma. (UCLA Health)
New insights into a high-fat diet’s role in the origin and progression of breast cancer. (APL Bioengineering)
Many patients with high-risk follicular thyroid cancer do not receive guideline-recommended radioiodine therapy. (American College of Surgeons)
A new generation of CAR T-cell therapy for solid tumors has shown potential to break down the immunosuppressive tumor microenvironment that protects cancer cells and make them susceptible to immunotherapy. (UCLA Health)
A combination of venetoclax (Venclexta) and chemotherapy led to clinical remission in 75% of patients with acute myeloid leukemia, as compared with historical rates of about 40% with chemotherapy alone. (Dresden University of Technology)
Five cancer research teams received a combined £100 million (~$134 million) from a joint U.S.-British program to investigate some of the most perplexing questions on the frontiers of cancer’s origins. (Cancer Research UK)
Akeso announced that the bispecific antibody cadonilimab led to a 24-month overall survival of 100% in metastatic cervical cancer patients with complete responses in a phase II study.
Total neoadjuvant therapy for locally advanced rectal cancer allows some patients to skip surgery altogether. (University of Texas MD Anderson Cancer Center)
The Department of Justice (DOJ) announced that two New Jersey men pleaded guilty to conspiring with doctors and other individuals to resell medications, including oncology drugs, previously purchased lawfully by hospitals and other healthcare organizations.
And the DOJ said that a former executive of ExThera Medical admitted to concealing the deaths of two cancer patients treated with the company’s blood filter device.
As expiration dates for key patents approach, the blockbuster cancer drug pembrolizumab (Keytruda) reigned as the biggest pharma moneymaker one more time, edging out the diabetes/weight-loss drug tirzepatide (Mounjaro, Zepbound). (BioSpace)
Long-term follow-up data for 1,900 patients suggest radiofrequency ablation for small kidney tumors is just as effective as surgery but safer and allows for quicker recovery. (Radiological Society of North America)
Use of vaginal estrogen had no association with cancer recurrence in a study of 2,800 women who survived endometrial cancer. (The Menopause Society)
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/120197
Author :
Publish date : 2026-03-06 17:40:00
Copyright for syndicated content belongs to the linked Source.
